Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:
Net Income	$ 406	$ 3,113
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for loan losses	700	550
Depreciation and amortization	581	417
Net amortization on securities	885	1,512
Increase in cash surrender value of bank owned life insurance	(69)
Amortization of core deposit intangible	58	16
Share based compensation expense	291	338
Net securities losses (gains)	1,112	(338)
Increase in accrued interest receivable	(759)	(131)
Increase in other assets	(3,929)	(1,268)
Increase (decrease) in accrued expenses and other liabilities	1,686	(202)
Net cash provided by operating activities	962	4,007
Cash flows from investing activities:
Purchases of securities available for sale	(148,637)	(26,033)
Purchases of securities, restricted	(80,235)	(59)
Purchases of securities held to maturity	(17,962)
Proceeds from sales of securities available for sale	198,763	46,553
Redemption of securities, restricted	79,380
Maturities, calls and principal payments of securities available for sale	15,712	51,395
Maturities, calls and principal payments of securities held to maturity	3,011	13,932
Net increase in loans	(35,409)	(63,715)
Proceeds from sales of other real estate owned, net	2,242
Purchase of premises and equipment	(1,008)	(1,570)
Net cash acquired in business combination	2,926
Net cash provided by investing activities	18,783	20,503
Cash flows from financing activities:
Net decrease in deposits	(34,066)	(35,121)
Net increase (decrease) in federal funds purchased	2,000	(15,500)
Net increase in FHLB advances	14,935
Repayment of acquired unsecured debt	(1,450)
Net increase in repurchase agreements	192	431
Net proceeds from issuance of common stock	151
Net proceeds from exercise of stock options	7
Repurchase of surrendered stock from vesting of restricted stock awards	(147)	(149)
Excess tax benefit (expense) from share based compensation	30	(9)
Cash dividends paid	(2,607)
Other, net	(192)
Net cash used in financing activities	(21,147)	(50,348)
Net decrease in cash and cash equivalents	(1,402)	(25,838)
Cash and cash equivalents at beginning of period	45,573	51,249
Cash and cash equivalents at end of period	44,171	25,411
Cash paid for:
Interest	1,712	1,792
Income tax	883	190
Noncash investing and financing activities:
Securities which settled in the subsequent period	12,905
Acquisition of noncash assets and liabilities:
Fair value of assets acquired	206,981
Fair value of liabilities assumed	$ 212,430